Description
Product Description
Insulin Glargine is a recombinant insulin analog developed for scientific research involving insulin signaling, glucose homeostasis, and long-acting hormone behavior. Structural modifications to the insulin molecule result in altered solubility characteristics, allowing researchers to study prolonged receptor engagement and sustained metabolic effects in experimental systems.
In laboratory research, Insulin Glargine is frequently used as a reference compound for investigating insulin receptor activation, downstream signaling pathways, and comparative pharmacodynamic behavior among insulin analogs. Its predictable biochemical profile supports reproducible experimentation across both cellular and animal-based metabolic models.
This compound is particularly relevant in studies focused on endocrine regulation, insulin sensitivity, and glucose uptake mechanisms. Researchers utilize Insulin Glargine to explore receptor binding kinetics, signal duration, and molecular responses under controlled experimental conditions.
Supplied as a high-purity raw material, Insulin Glargine enables flexible experimental design, including dose–response analysis, comparative insulin analog studies, and long-acting hormone modeling. Each batch undergoes strict analytical verification to ensure identity, purity, and batch consistency suitable for advanced research use.

Product Specifications
| Item | Description |
|---|---|
| Product Name | Insulin Glargine |
| Synonyms | Insulin glargine analog |
| CAS Number | 160337-95-1 |
| Molecular Formula | C267H404N72O78S6 |
| Molecular Weight | ~6063.9 g/mol |
| Amino Acid Sequence | Modified human insulin analog |
| Peptide Type | Recombinant peptide |
| Form | Lyophilized powder or solution (custom) |
| Purity | ≥99% (HPLC) |
| Strength Options | Customizable |
| Appearance | White to off-white powder or clear solution |
| Identity Verification | HPLC, MS |
| Solubility | Soluble in suitable aqueous buffers |
| Packaging | Sterile glass vial or cartridge |
| Storage Condition | 2–8 °C or −20 °C (long-term) |
| Intended Use | Research use only |
Applications
Insulin Glargine is widely applied in experimental research related to metabolic and endocrine systems.
Typical research applications include:
Insulin receptor signaling studies
Glucose metabolism and uptake research
Long-acting insulin behavior modeling
Comparative insulin analog studies
Endocrine regulation research
Metabolic disorder mechanism investigations
In vitro and in vivo insulin sensitivity models
Pharmacodynamic and duration-of-action studies
These applications position Insulin Glargine as an important reference material in insulin-related research programs.

Packaging
The product is supplied in sterile, sealed containers. Packaging options include lyophilized powder vials or liquid formulations depending on research requirements. Bulk supply and customized specifications are available for institutional research use.
Storage & Transportation
Store at 2–8 °C for short-term use or at −20 °C for long-term storage. Protect from light and repeated freeze–thaw cycles. Cold-chain transportation is recommended to maintain material stability.
Inquiry & Technical Consultation
For Certificates of Analysis, batch documentation, or technical consultation related to Insulin Glargine, please submit an inquiry through the contact form. Support is available for qualified research users.
Disclaimer
This product is intended for research use only.
Not for human or veterinary use.
All handling and experimental applications must comply with applicable laboratory and regulatory requirements.


Reviews
There are no reviews yet.